Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of Inhaled AERO-002 vs Active Comparator in Healthy Volunteers
NCT07802730Phase 1Completed
- Sponsor
- AeroRx Therapeutics
- Start
- Sep 2026
- Primary completion
- Oct 2026
- Countries
- 1
01
Overview
Phase 1, randomised trial of glycopyrrolate metered dose inhaler in chronic obstructive pulmonary disease (COPD) (2 arms), sponsored by AeroRx Therapeutics. Primary endpoints: Area Under the Curve and Maximum Observed Plasma Concentration. Started Sep 2026; status: completed.
02
Drugs
glycopyrrolate metered dose inhaler
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT07802730.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07802730.